HCPLive

Product News

Latest

Combo Cystic Fibrosis Therapy Approved
The US Food and Drug Administration (FDA) on Thursday approved Orkambi (lumacaftor/ivacaftor/Vertex) to treat cystic fibrosis patients age 12 and older with two copies of the F508del mutation in the CFTR gene.
Hepatitis C: Good News on Genotype 1b Drug Combo
Results from the Turquoise III trial show an antiviral combo cured patients with chronic hepatitis C genotype 1b infections, according to data to be released June 26 at the International Symposium on Viral Hepatitis and Liver Diseases in Berline, Germany.
New Antiplatelet Drug Approved
The US Food and Drug Administration today approved the use of cangrelor (Kengreal/The Medicines Company) for adults undergoing percutaneous coronary interventions (PCI).
Brain Implant for Parkinson’s Disease Approved
The US Food and Drug Administration (FDA) granted approval for the Brio Neurostimulation System– the second brain implant stimulation device to aid in the reduction of Parkinson’s disease symptoms and essential tremor.
FDA Approves Toddler Use for Seizure Drug
The FDA extended the use of toparimate, an anti-seizure drug, to children as young as 2.
FDA Okays Lung Drug
The US Food and Drug Administration approved a new use for sirolimus, treating a rare lung disease.

Most Popular

$vacMongoViewPlus$ $vAR$